|
|
|
Volumn 25, Issue 17, 2007, Pages 3247-
|
|
Results of a safety and immunogenicity study of an early-stage investigational rPA102 vaccine as compared to the FDA licensed anthrax vaccine (anthrax vaccine adsorbed (AVA. BioThrax)).
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRAX TOXIN;
ANTHRAX VACCINE;
BACTERIAL ANTIGEN;
BACTERIAL TOXIN;
RECOMBINANT VACCINE;
COMPARATIVE STUDY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IMMUNOLOGY;
LICENSING;
NOTE;
UNITED STATES;
ANTHRAX VACCINES;
ANTIGENS, BACTERIAL;
BACTERIAL TOXINS;
HUMANS;
LICENSURE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VACCINES, SYNTHETIC;
|
|
EID: 34249745134
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
